Ra Medical Systems, which is commercializing excimer lasers used to treat dermatological and vascular diseases, raised $66 million by offering 3.9 million shares at $17, above the range of $14 to $16. The Carlsbad, CA-based company had originally filed to offer 3.3 million shares at the same range.
Ra Medical Systems plans to list on the NYSE under the symbol RMED. Piper Jaffray and Cantor Fitzgerald acted as lead managers on the deal.
